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Nanotechnology is the term given to those areas of science and engineering where the phenomena take 
place at nanoscale dimensions. Nanoparticles are particles with <100 nm in one dimension. They have 
different physical, chemical, electrical and optical properties than those that occur in bulk samples of the 
same material. Understanding these nanoscale properties and finding ways to engineer new nanomaterials 
will have a revolutionary impact, from more efficient energy generation and data storage to improved 
methods for diagnosing and treating diseases. Nanotechnology is poised to become a major factor in the 
world’s economy and part of our everyday lives in the near future. Hundreds of tonnes of nanoparticles 
already enter the environment annually, but still very little is known of their interactions with biological 
systems. Recent studies indicate that some nanoparticles are not completely benign to biological and 
environmental targets. The challenge for toxicologists is to identify key factors that can be used to predict 
toxicity, permit targeted screening, and allow material scientists to generate new, safer nanoparticles with 
this structure-toxicity information in mind. The aim of this paper is to summarize some known facts about 
nanomaterials and discuss future perspectives, regulatory issues and tasks of the emerging branch of 
toxicology, that is, nanotoxicology.
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Society and economy are likely to benefit from 
the advantages of nanotechnology in structural 
engineering, electronics, optics, consumer products, 
alternative energy, soil and water remediation, medical 
uses as therapeutics, diagnostic, or drug delivery 
devices. Physicist Richard P. Feyman was first who 
talked about the concept of nanoscience in 1959 in 
his key lecture at the annual meeting of the American 
Physical Society, and the term nanotechnology was 
coined in 1974 by a Japanese researcher Nario 
Taniguchi to mean “precision machining with tolerance 
of a micrometer or less”. It refers to engineering on 
the molecular and atomic levels.
Despite bright outlooks for the future of 
nanotechnology, there is an increasing concern 
that intentional or unintentional human exposure to 
some types of engineered nanoparticles may lead to 
significant adverse health effects (1). In addition, there 
is a concern about environmental contamination and 
associated effects on the ecosystem, which could have 
significant societal implications. A growing public 
debate is emerging on whether the environmental 
and social costs of nanotechnology outweigh its many 
benefits (2-5). The questions about the side effects of 
products of nanotechnologies are pertinent, since the 
potential for exposure to nanoparticles will increase 
as the quantity and types of nanoparticles used in the 
society grow.
As the outcome of all these debates and concerns, 
a new branch in toxicological research has emerged 
with the aim to investigate possible harmful effects of 
exposure to nanomaterials (6, 7). Nanotoxicology also 
encompasses the properties of nanomaterials used in 
toxicity studies. In addition, nanotoxicology is involved 
in proposing reliable, robust, and data-assured test 
protocols for nanomaterials and in human and 
environmental risk assessment of nanomaterials.
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NANOPARTICLES AND THEIR 
CHARACTERIZATION
Nanoparticles range between 1 nm and100 nm, 
which is the same size covered by ambient particles 
which have been termed “ultrafine” particles. Ultrafine 
particles and engineered nanoparticles have several 
characteristics in common, but there are also 
significant differences. Properties of great toxicological 
importance are common to both. Both consist of 
primary particles below 100 nm in size, which provide 
a large surface area per unit mass and potentially high 
surface reactivity. Both tend to form agglomerates 
when suspended in gases or liquid, depending on the 
concentration and the chemistry of the suspension 
medium. Most of the ambient ultrafine particles are 
generated as heterogeneous aggregates of primary 
particles (e. g. combustion soot particles), whereas 
most of the engineered nanoparticles are generated 
as monodispersed individual particles (e.g. quantum 
dots, nanosized TiO2, and nanosized ZnO), (Figure 1 
and 2).
In theory, nanoparticles can be produced from 
nearly any chemical, however most nanoparticles 
that are currently in use have been made from 
transitional metals, silicon, carbon (single-walled 
carbon annotates, fullerenes), and metal oxides. 
In many cases engineered nanoparticles exist as 
nanocrystals.
By making particles of just a few hundred atoms 
one creates an enormous amount of surface, which 
tends to become electrically charged, and thus 
electro-chemically reactive. Unique electrical and 
chemical properties make them highly desirable for 
applications in commercial, medical, environmental 
and military sectors (8), (Figure 3).
Characterization of a dose of nanomaterials 
for toxicogical investigation is very complex when 
compared with chemical toxicants. With the latter, the 
verification of dose or concentration is usually relatively 
straightforward. It is based on the characterization of 
composition and purity of the material tested. But with 
nanoparticles, apart from bulk chemistry, a variety 
of other material attributes have to be considered, 
including size and size distribution, shape, crystallinity, 
porosity, surface roughness, solubility, surface area, 
state of dispersion, surface chemistry and many other 
physico-chemical properties (9). Among all these, 
four physical parameters are deemed relevant for 
nanoparticles when assessing their toxicity: particle 
number, length, surface area, and mass concentration 
(10).
Transmission electron microscopy (TEM) and 
scanning electron microscopy (SEM) are gold 
standards for the evaluation of particle size distribution 
and shape (Figure 1 and 2) in the context of toxicity 
screening studies. Both provide specific physico-
chemical information on engineered nanomaterials.
Figure 1. Electron microscopy photos of nanosized titanium dioxide. 
Photo 1: Scanning electron microscopy (SEM; photo by Tatti, 
Drobne, Milani 2006, DB Strata 235). 
Figure 2 Transmission electron microscopy (TEM; photo by Pipan, 
Drobne 2006, TEM, Philips CM 100) of nanosized titanium 
dioxide. SEM and TEM are two methods of choice to 
investigate particle size, shape, and structure. The resolution 
of SEM has progressed in recent years and approached that 
of TEM.
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INTERACTIONS BETWEEN NANOPARTICLES 
AND BIOLOGICAL SYSTEMS
The main questions scientists are currently 
facing are: what is the mechanism of toxic action 
of nanoparticles; how does the reactive surface of 
nanoparticles interact with “wet internal environment 
inside the body”; and what is the relative contribution 
of particle size versus particle composition in the 
overall toxicity of nanoparticles. Definitive answers 
to all these questions are currently lacking although 
research is underway in a number of centres.
Al though the chemical  composi t ion of 
nanomaterials is known, rearrangements, for 
example, of carbon into new polymeric structures, or, 
similarly, the restructuring of metal oxide or crystalline 
lattice, are worthy of toxicological considerations. 
The experiences with the different forms of silica 
and asbestos have taught us that the physical / 
chemical properties of materials can be very important 
determinants of the toxicological potential. The very 
surface area and quantum chemistry effects that the 
nanosciences are exploring and hope to manipulate, 
are also known to be important in determining the 
manner in which biological systems function and 
interact with the physical world (11).
The multitude of available in vitro studies dealing 
with the mechanism of nanoparticle uptake in different 
cell types as well as the few studies on in vivo uptake 
and nanoparticle distribution in animal models 
demonstrate that there is no single common uptake 
mechanism for nanoparticles (12, 13).
The upper size limit for the toxicity of nanoparticles 
(ultrafine particles) is not fully known, but is thought 
to lie between 65 nm and 200 nm (14). In vitro
studies performed on cell cultures have confirmed 
the increased ability of nanoparticles to produce 
free radicals which can cause cellular damage (15). 
Generation of reactive oxygen species (ROS) upon 
exposure of cells to particulate matter is nowadays 
considered a major contributor to nanoparticle toxicity. 
The cell membrane, mitochondria, and cell nucleus 
are considered relevant for possible nanoparticle-
induced toxicity (13), (Figure 1). In the light of current 
knowledge, it seems that the size effect is considerably 
more important for nanoparticle toxicity than the 
actual composition of the material. In contrast, in
vivo pulmonary inflammation and cytotoxicity studies 
on rats show that TiO2 toxicity does not depend on 
particle size and surface area (29).
Over the last five years the number of papers on 
the ongoing work in nanotoxicology has increased 
exponentially. However, it is still not possible to draw 
any common conclusion about how nanoparticles 
interact with biological systems. In different in vivo and 
in vitro studies the authors find both dose-dependent 
and dose-independent response to nanoparticles 
(17-20). The type of response is obviously related to 
the measured parameters. In the same study, some 
measured parameters may be dose-dependent while 
others may not. It is interesting and worth mentioning 
that the highest doses do not necessarily provoke the 
most pronounced response neither in in vitro nor in 
in vivo studies.
DEVELOPMENT OF TEST PROTOCOLS FOR 
NANOMATERIALS
It is not known whether the toxicological assessment 
of one type and source of nanomaterial will be 
sufficient to assess the toxicity of the same class/type 
of nanomaterial produced by a different process. The 
manufactured materials may also be treated with 
coatings, or other surface modifications, in order to 
generate mono-dispersed suspensions that enhance 
their unique properties. The extent to which surface 
modifications of intentionally produced nanomaterials 
affect their toxicity is not known.
In addition, because of the wide variety of properties 
among nanomaterials, each type can provoke its own 
Figure 3 Projected stages of nanotechnology development (adopted by 
EPA Nanotechnology White Paper, 2007)
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unique biological response. As a result, different types 
of nanomaterials should be categorized, characterized 
and tested separately, although certain concepts of 
nanotoxicology based on the small size is likely apply 
to all nanomaterials (7).
The challenge for nanotoxicologists is not to test 
every variation of a new nanoparticle generated, but 
instead to identify the key factors that can be used to 
predict toxicity.
By now, several strategies to screen for the toxicity 
of nanoparticles have been proposed by various 
investigators, and discussed in a number of thorough 
reviews and related documents (5-7, 21-25).
More refined approaches to nanomaterial 
characterization and toxicological evaluation will 
emerge with time, but at the moment, the existing 
test protocols for conventional chemicals are generally 
recognized as a good starting point. However, these 
tests have to include additional physical metrics.
Regulatory agencies, professional societies, 
academic community, NGOs, and industry are involved 
in developing and validating standard guidelines for 
toxicity testing strategies of nanomaterials to pre-
empt and avoid unwanted surprises from intentional 
or unintentional exposures to nanomaterials (5, 25). 
These methods have to be timely and cost–effective, 
and have to provide toxicological information for the 
diversity of nanomaterials.
HUMAN AND ENVIRONMENTAL RISK 
ASSESSMENT OF NANOMATERIALS
Risk assessment is the evaluation of scientific 
information on the hazardous properties of a variety 
of agents, the dose-response relationship, and the 
extent of exposure of humans or environmental targets 
to these agents. The product of risk assessment is a 
statement about the likelihood of exposed humans 
and the ecosystem with all its components being 
harmed and to what degree (risk characterization).
The following key aspects of risk assessment 
are addressed, as they relate to nanomaterials: a) 
identification of chemical and physical properties; b) 
environmental fate; c) environmental detection and 
analysis; d) human and ecosystem exposure; and e) 
human and ecosystem effects (5, 22, 25, 26).
a) Identification and characterization of chemical 
substances and materials is an important first step 
in assessing their risk. The diversity and complexity 
of nanomaterials makes chemical identification 
and characterization more difficult than with other 
chemicals. A broader spectrum of properties will be 
needed to sufficiently characterize a given nanomaterial, 
evaluating the hazard and assess the risk.
b) Fundamental properties concerning the 
environmental fate of nanomaterials are not well 
understood. Models used to assess the environmental 
fate and exposure to conventional chemicals are not 
applicable to intentionally produced nanomaterials. 
Depending on the relevance of chemical properties or 
transformation, new models may have to be developed 
to provide estimations for new materials. However, a 
certain amount of reliable experimental data must 
be acquired before the environmental fate, transport, 
and multimedia partitioning of nanomaterials can be 
effectively modelled.
c) The challenge in detecting nanomaterials in 
the environment is compounded not only by the 
extremely small size of the particles, but also by their 
unique physical structure and physico-chemical 
characteristics. The variety of physical and chemical 
properties can significantly affect the extraction and 
analytical techniques that can be used for the analyses 
of a specific nanomaterial.
There is a range of methods available for 
measuring nanostructured aerosol number, surface 
area, and mass concentration, although only a few of 
these are directly applicable to monitoring exposure 
to nanostructured aerosols. Maynand et al. (27) have 
proposed a universal aerosol sampler that would log 
exposure against aerosol number, surface area and 
mass concentration simultaneously.
In liquid media, the available technologies for size 
fractionation and collection of nanoparticle fractions 
include size-exclusion chromatography, ultrafiltration, 
and field-flow fractionation (9).
For more definitive analytical data, single-particle 
analytical techniques can be employed. Single particle 
laser microscope mass spectrometry (LAMMS) can 
provide chemical composition data on single particles 
from a collected fraction (28). Electron microscopy 
techniques can provide particle size, morphological 
and chemical composition information for a single 
nanoparticle (Figure 1).
It will be necessary to monitor products that 
incorporate nanoparticles and nanofibres throughout 
their life, from manufacture to disposal, in order to 
estimate the probability of environmental emissions, 
particularly from disposal and waste management 
processes.
d) Human and ecosystem exposure account for a 
series of events beginning with external mechanisms 
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that make a chemical / nanoparticle available for 
absorption or other mode of entry and ending with the 
chemical or its metabolite reaching the target organ, 
depending on the nature of the chemical and route of 
exposure. There are several tools to assess exposure, 
including monitoring data, exposure models, and 
the use of analogous data for the existing chemicals, 
summarized in the US Environmental Protection 
Agency Nanotechnology White Paper 2007 (5).
e) Assessing nanomaterial toxicity is extremely 
complex and multifunctional, and is potentially 
influenced by a variety of physico-chemical properties 
of nanoparticles. At the moment, there is a significant 
gap in our knowledge of the environmental, 
health and ecological implications associated with 
nanotechnology. However, an exponential increase 
in scientific papers over the last five years reflects the 
ongoing work and the importance of this area (1).
Human and environmental risk assessment of 
nanomaterials will be the central goal of nanotoxicology 
in the future. Only through development of a sound 
evidence base in all aspects of hazard and exposure 
assessment can we hope to generate an informed 
and reliable risk assessment of nanoparticles. Risk 
assessment is of key importance to the insurance 
industry as well as the regulatory agencies that are 
responsible for formulating exposure and safety 
guidelines.
REGULATION OF ENGINEERED 
NANOMATERIALS IN EUROPE AND USA
 A new European chemicals regulation (REACH) 
was adopted in December 2006. REACH stands for 
Registration, Evaluation, Authorization and Restriction 
of Chemicals. REACH Regulation EC No. 1907/2006 
and Directive 2006/121/EC amending Directive 
67/548/EEC were published in the Official Journal 
on 30 December 2006. REACH entered into force 
on 1 June 2007.
Some suggest that REACH’s applicability to 
nanoparticles and nanomaterials is unclear. While 
it is true that REACH does not specifically mention 
nanoparticles or nanoscale materials anywhere in its 
eight hundred plus pages of text, both the restriction 
and authorization processes can also be applied to 
substances produced or imported in volumes below 
one tonne per year. If substances in the nano-scale 
fall under the scope of REACH, their health and 
environment properties must therefore be assessed 
following the provisions of this Regulation. However, 
the methodologies for identifying hazards and 
evaluating risks of substances at the nano-scale need 
to be further refined in years to come. It is important 
to stress that engineered nanoparticles have to be 
treated as new substances as defined by REACH, and 
not as “a refinement of particle size distribution”. At 
present, laboratory guidelines or national chemicals 
policies do not distinguish between handling nano- or 
macroparticles.
The US EPA has also suggested that the overall 
risk approach for conventional chemicals is generally 
also applicable to nanomaterials (5).
Environmental and health dangers posed by 
synthetic nanoparticles require that the following 
actions are taken in the near future: a) establishment 
of national and international interdisciplinary research 
centres to study the potential hazards of synthetic 
nanoparticles; b) establishment of a central information 
office for the general public; and c) establishment of 
public dialogue on the opportunities and risks posed 
by synthetic nanoparticles.
CONCLUDING REMARKS
According to some estimates, nanotechnology 
promises to far exceed the impact of the Industrial 
Revolution and is projected to become a US$ 1 trillion 
market by 2015.
The importance of nanotechnologies to our 
well being is beyond debate, but its potential 
adverse impacts need to be studied all the more. 
Nanotoxicology as a new discipline should make 
an important contribution to the development of a 
sustainable and safe nanotechnology.
An improved understanding of the risk factors 
related to nanomaterials in the human body and the 
ecosystem will aid future development and exploitation 
of a variety of nanomaterials.
Issues related to new nanoparticles are in the 
headlines due to the fear of their escaping into the 
environment. In fact, we have lived with sub-micron 
sized particles around us forever. The introduction of 
man-made versions has just brought to light the fact 
how little we know about their toxic effects.
Awareness is growing about the need to develop 
an infrastructure for characterizing and measuring 
nanomaterials in complex matrices and for developing 
reference materials, both for calibration of instruments 
used for assessing exposure and dosimetry, and for 
benchmarking toxicity tests.
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Public expects that new or emerging technologies 
meet higher safety requirements than tried and tested 
technologies. Failure to meet these requirements 
may result in public fear or even rejection of 
nanotechnology-based products, which often 
essentially improve the quality of life of individuals, 
groups of people, or even nations.
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Izvle~ek
NANOTOKSIKOLOGIJA ZA VARNO IN TRAJNOSTNO NANOTEHNOLOGIJO
Nanomateriali izbolj{ujejo kvaliteto na{ega `ivljenja, zato bo njihova uporaba na razli~nih podro~jih 
`ivljenja dramati~no narasla. Po nekaterih ocenah bo imela nanotehnologija ve~ji vpliv na dru`bno kot ga 
je imela industrijska revolucija. Kot posledica razmaha nanotehnologije se bo pove~ala poklicna in javna 
izpostavljenost nanodelcem ter izpostavljenost okolja. Nanodelci, ki nas najbolj zanimajo, so strukture, ki 
imajo v eni dimenziji manj kot 100 nm, in jih je izdelal ~lovek. Njihove lastnosti se zaradi njihove majhnosti 
bistveno razlikujejo od lastnosti, ki jih imajo ve~ji delci enake kemijske sestave. [ele v zadnjem ~asu so se 
za~ela pojavljati vpra{anja in vzpodbujati raziskave o potencialni nevarnosti nanodelcev. Trenutni rezultati 
toksikolo{kih {tudij potrjujejo kvarne u~inke nanodelcev in navajajo, da nanodelci najverjetneje delujejo na 
organizem preko oksidativnega stresa. [tudije nakazujejo {tevilne posebnosti nanodelcev pri interakcijah 
s celicami, tkivi in organizmi. Najverjetneje je ta trenutek pomembno pridobiti ~im ve~ ustreznega znanja 
za oblikovanje regulative na podro~ju varne proizvodnje in uporabe nanodelcev. Namen prispevka je 
povzeti `e znana dejstva o nanodelcih in predstaviti naloge nove smeri v toksikologiji, nanotoksikologije. 
V prispevku je povzeta najnovej{a regulativa na podro~ju ugotavljanja in zagotavljanja varnosti proizvodov 
nanotehnologij, navedene so nekatere koristne baze podatkov, razprave ter nacionalne in mednarodne 
smernice na podro~ju nanotehnologije.
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